PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 11916100

Developing an action plan for obesity education.

P Kopelman
View original source ↗Export metadata ↓

Abstract

Obesity education has long been neglected. Medical training continues to devote little time to education on obesity and its comorbidities, and practising physicians often feel ill equipped and poorly supported when dealing with overweight and obese patients. A European action plan for obesity education is required, to act at all levels--government, education providers and trainers, media, health professionals and patients-to improve understanding of obesity as a chronic but manageable medical condition.

Explore related subjects

Congresses as TopicEducation, MedicalEducation, Medical, ContinuingEuropeHealth EducationHumansObesityPatient Education as TopicJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Kopelman. 2001. Developing an action plan for obesity education.. https://doi.org/10.1038/sj.ijo.0801933

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

On-demand therapy for gastroesophageal reflux disease.

The following pages summarize the proceedings of a symposium held in May 2006 on the emerging role of on-demand therapy for gastroesophageal reflux disease (GERD). Medical therapy for GERD has undergone significant change in recent years with the advent of effective, but expensive, antisecretory agents. On-demand (patient-driven) therapy is attractive to payers and patients, because it appears to be both cost-effective and convenient. Many individuals appear to accept occasional symptomatic breakthrough in exchange for personal control of their disease. On-demand therapy should be distinguished from intermittent therapy, which is either patient- or physician-driven, but which requires intermittent episodes of continuous therapy followed by discontinuation until symptoms recur. Proton pump inhibitors appear to be effective on-demand agents despite theoretical pharmacodynamic limitations for this class of drug. The available data support the use of on-demand therapy for GERD in uninvestigated reflux disease, nonerosive reflux disease, and possibly mild esophagitis as well. On-demand therapy should not be considered for patients with severe esophagitis.

Congresses as Topic↗